Publications by authors named "J Schachter"

Claim this Profile
R
Randomized, double-blind, phase III LEAP-003 study of first-line lenvatinib plus pembrolizumab versus placebo plus pembrolizumab for unresectable or metastatic melanoma.
A Arance, M-A Berciano-Guerrero, J Guo, M S Carlino, P A Ascierto, J Schachter

Ann Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol for quantifying extracellular and intracellular ATP from macrophages upon inflammasome activation using a luciferin-luciferase technique.
Julieta Schachter, Adriana Guijarro, Pablo J Schwarzbaum, Pablo Pelegrín

STAR Protoc· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma extracellular vesicle surface-located GAS6/PROS1 and CD39/CD73 attenuate inflammation.
Martina P Fabiano, Alan M Adamczyk, Olesia A Gololobova, Ignacio G Mazzitelli, María L Leicaj, Julieta Schachter

Cell Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Checkpoint Inhibitors in the Treatment of Advanced Melanoma in Older Patients: An Overview of Published Data.
Marko Lens, Jacob Schachter

Cancers (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, prevalence, and mortality of localized scleroderma in Quebec, Canada: a population-based study.
Stephanie Ghazal, Anastasiya Muntyanu, Katherine Aw, Mohammed Kaouache, Lauren Khoury, Jordana Schachter

Lancet Reg Health Am· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis